Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
34178
Description
VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT02392455
Link
https://clinicaltrials.gov/show/NCT02392455
Keywords
Versions (2)
- 1/15/19 1/15/19 -
- 5/14/19 5/14/19 -
Copyright Holder
GSK group of companies
Uploaded on
January 15, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455
Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
age 18 or older
boolean
ID.2
Item
men and women locally advanced, metastastic and/or recurrent nsclc with adenocarcinoma histology for which vargatef treatment is indicated according to summary of product characteristics (smpc)
boolean
ID.3
Item
after first line therapy; second-line therapy not yet started
boolean
ID.4
Item
standard 21-day-cycles docetaxel treatment according to smpc possible
boolean
ID.5
Item
written informed consent
boolean
ID.6
Item
contraindications according to the smpc of vargatef or docetaxel
boolean
ID.7
Item
more than one systemic therapy for treatment of nsclc in palliative setting
boolean
ID.8
Item
current partcipation in another non-interventional study or a clinical trial
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
breastfeeding
boolean